Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, Pils M, Blömeke L, Post J, Kulawik A, Jürgens D, Rossberg WM, Hümpel M, Bannach O, Otto M, Araujo JA, Willuweit A, Willbold D. Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease Heliyon 29;9(8):e18443, (2023) https://pubmed.ncbi.nlm.nih.gov/37609390/
Pils M, Dybala A, Rehn F, Blömeke L, Bujnicki T, Kraemer-Schulien V, Hoyer W, Riesner D, Willbold D, Bannach O Development and implementation of an internal quality control sample to standardize oligomer-based diagnostics of Alzheimer's disease Diagnostics 13, 1702 (2023) https://doi.org/10.3390/diagnostics13101702
Kass B, Schemmert S, Zafiu C, Pils M, Bannach O, Kutzsche J, Bujnicki T, Willbold D. Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo. Cell Rep Med. 3(5):100630, (2022) https://doi.org/10.1016/j.xcrm.2022.100630
Schemmert S, Schartmann E, Zafiu C, Kass B, Hartwig S, Lehr S, Bannach O, Langen KJ, Shah NJ, Kutzsche J, Willuweit A, Willbold D. Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer's Mice with Full-blown Pathology. Mol Neurobiol. 56(3):, 2211-2223 (2019) https://10.1007/s12035-018-1209-3 https://www.ncbi.nlm.nih.gov/pubmed/30003517
Kühbach K, Hülsemann M, Herrmann Y, Kravchenko K, Kulawik A, Linnartz C, Peters L, Wang K, Willbold J, Willbold D, Bannach O. Application of an amyloid beta oligomer standard in the sFIDA assay. In: Biomarkers of Alzheimer's Disease: The Present and the Future. Eds. Sylvain Lehmann, Charlotte Elisabeth Teunissen. , 39-44 (2017) ISBN 9782889450411
Bannach O, Reinartz E, Henke F, Dreßen F, Oelschlegel A, Kaatz M, Groschup M H, Willbold D, Riesner D and Birkmann E Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases Vet Microbiol 166, 102-108 (2013) http://dx.doi.org/10.1016/j.vetmic.2013.05.021
Bannach O, Riesner D Prions Overview In: The Encyclopedia of Biological Chemistry. William J. Lennarz, M. Daniel Lane (eds.), Elsevier Inc. 3, 571-575 (2013)
Wang-Dietrich L, Funke SA, Kühbach K, Wang K, Besmehn A, Willbold S, Cinar Y, Bannach O, Birkmann E, Willbold D The Aβ oligomer count in CSF is a biomarker for Alzheimer’s disease. J. Alzheimers Dis. 34, 985-994 (2013)
Bannach O, Birkmann E, Reinartz E, Jaeger K-E, Langeveld JP, Rohwer RG, Gregory L, Terry LA, Willbold D, Riesner D Detection of Prion Protein Particles in Blood Plasma of Scrapie Infected Sheep PLoS ONE 7, e36620 (2012) http://dx.doi.org/10.1371/journal.pone.0036620 full text open access
Hübinger S, Bannach O, Funke SA, Willbold D, Birkmann E Detection of alpha-synuclein aggregates by fluorescence microscopy Rejuvenation Res. 15, 213-216 (2012)
Birkmann E, Henke F, Funke SA, Bannach O, Riesner D, Willbold D A highly sensitive diagnsotic assay for aggregate-related diseases e.g. prion disease and Alzheimer's disease. Rejuvenation Res. 11, 359-363 (2008)
